reference/18188049

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18188049

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	139
issn	0753-3322
pageRange	135-139
publicationName	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
startingPage	135
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6c2c59c24c713601e70b11151fa7eb0d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fe0ebb6923dfe4af5d98e8386099df46 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4edde894c31d91a6f8f1b5fbec12abbb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_49fc5a2e023bba14be5f597c731a2718
bibliographicCitation	Huang G, Cui F, Yu F, Lu H, Zhang M, Tang H, Peng Z. Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma. Biomed Pharmacother. 2015 May;72():135–9. doi: 10.1016/j.biopha.2015.04.013. PMID: 26054687.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c43fd0870bbab88a18d7e64acfb46bcd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5685-1811 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbaed15b1b5db24fc021462e60978688 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fb2858e1a6c686666c4cb3a2b40f341 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7fe8839e9ff6f4ca6c4bfa92e301e90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_313da10572924ddd62b84b3fb53b083b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47dfd444b0a6e9290b648755e7441dca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb9b7b46246101941772b32d726861a7
date	201505
identifier	https://doi.org/10.1016/j.biopha.2015.04.013 https://pubmed.ncbi.nlm.nih.gov/26054687
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1156 https://portal.issn.org/resource/ISSN/0753-3322
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma
discusses	http://id.nlm.nih.gov/mesh/M0369371 http://id.nlm.nih.gov/mesh/M0413549 http://id.nlm.nih.gov/mesh/M0517020
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015536 http://id.nlm.nih.gov/mesh/D000230Q000473 http://id.nlm.nih.gov/mesh/D024101Q000378 http://id.nlm.nih.gov/mesh/D000230Q000378 http://id.nlm.nih.gov/mesh/D013274Q000473 http://id.nlm.nih.gov/mesh/D013274Q000378 http://id.nlm.nih.gov/mesh/D037761Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005753Q000378 http://id.nlm.nih.gov/mesh/D007150 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D013270Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07b5cd5e060d4d36723dc0f3c9d56a96 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5961 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5892 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d51d16e6a987f38134ef8f5ed4953972

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23409

Total number of triples: 55.